A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|68|4-6|333-340

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 333-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Docetaxel and Capecitabine in Patients with Metastatic or Recurrent Gastric Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 190-195

Karger

Access to resources Recommend Favorite

Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 330-337

Karger

Access to resources Recommend Favorite

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J.   Gamucci Teresa   Pollera Camillo F.   Di Costanzo Francesco   Nuzzo Carmen   Gabriele Angela   Signorelli Carlo   Gasperoni Silvia   Ferraresi Virginia   Giannarelli Diana   Cognetti Francesco   Zeuli Massimo  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite

A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 232-236

Karger

Access to resources Recommend Favorite

A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 255-260

Karger

Access to resources Recommend Favorite